Sheel Biotech Ltd
₹ 39.0
-2.50%
01 Apr
3:31 p.m.
About
Incorporated in November 199, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
Key Points
- Market Cap ₹ 79.4 Cr.
- Current Price ₹ 39.0
- High / Low ₹ 95.6 / 37.8
- Stock P/E 5.53
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 14.5 %
- ROE 13.3 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 17.2%
Cons
- Company has a low return on equity of 12.5% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 182 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 63 | 84 | 89 | 103 | 110 | |
| 56 | 78 | 80 | 89 | 95 | |
| Operating Profit | 7 | 6 | 9 | 14 | 15 |
| OPM % | 10% | 8% | 10% | 14% | 14% |
| 0 | 0 | 0 | 0 | 1 | |
| Interest | 1 | 1 | 2 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 5 | 6 | 12 | 13 |
| Tax % | -0% | 2% | 20% | 15% | 17% |
| 5 | 5 | 5 | 10 | 11 | |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.12 |
| Dividend Payout % | -0% | 28% | 25% | 12% | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 15 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 69 |
| 21 | 24 | 19 | 24 | 17 | 27 | |
| 4 | 10 | 11 | 10 | 12 | 13 | |
| Total Liabilities | 82 | 93 | 94 | 106 | 113 | 124 |
| 8 | 8 | 8 | 7 | 7 | 7 | |
| CWIP | -0 | 0 | -0 | -0 | -0 | -0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| 75 | 84 | 85 | 98 | 105 | 116 | |
| Total Assets | 82 | 93 | 94 | 106 | 113 | 124 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 2 | 9 | -1 | 9 | ||
| -2 | -2 | -0 | -2 | ||
| -0 | -7 | 2 | -7 | ||
| Net Cash Flow | -0 | -0 | 0 | -0 | |
| Free Cash Flow | 1 | 8 | -1 | 8 | |
| CFO/OP | 37% | 105% | 3% | 75% |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 182 |
| Inventory Days | 55 | 120 | 177 | 263 | 272 |
| Days Payable | 30 | 85 | 75 | 37 | 29 |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 426 |
| Working Capital Days | 348 | 274 | 255 | 256 | 253 |
| ROCE % | 7% | 10% | 15% | 14% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Production Capacity of Tissue Culture Planting Materials Million units per annum |
|
||
| Geographic Presence (States in India) Number |
|||
| Number of Farmer Producer Organizations (FPOs) Managed Number |
|||
Requires Premium
Requires Premium
Documents
Announcements
-
Updates
10 March 2026 - MCA company details: Sheel Biotech (CIN L24239DL1991PLC046531), paid-up capital Rs203,525,500, active, AGM 30/09/2025.
-
Updates
5 February 2026 - Sheel Biotech Limited has informed regarding ''. receipt of Letter of Intent cum Work Order having contract price of Rs. 12.95 Crore. by National Agricultural …
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
5 February 2026 - Sheel Biotech Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
5 February 2026 - Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q3 FY 2025-26
-
Reply to Clarification- Financial results
5 February 2026 - Revised H1 30.09.2025 financials, corrected XBRL; IPO proceeds Rs3,402.00L, Rs2,320.05L unutilised.
Business Profile[1]
The company is engaged in the cultivation, development, processing, and supply of plants across multiple categories, including field crops, fruits, vegetables, and ornamental plants. Tissue culture techniques and organic farming practices drive its operations.